Trial intelligence / Profile preview

First-in-human study of FLX475 in healthy volunteers

NL-OMON26146Phase 1Recruiting

Sponsor
RAPT Therapeutics
Start
Nov 2017
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in cancer comparing FLX475 with Placebo (2 arms). Started Nov 2017; status: recruiting.

02

Drugs

tivumecirnon
03

Conditions

cancer

Beyond the preview

Go deeper on NL-OMON26146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call